Jun-Min Zhou

1.1k citations
13 papers · 798 · 1 hit paper · h-index 11

Impact in

  • Oncology top 10%
    • Peptidase Inhibition and Analysis
    • Viral-associated cancers and disorders
    • Pancreatic and Hepatic Oncology Research
  • Surgery top 10%
    • Cholangiocarcinoma and Gallbladder Cancer Studies

Papers in

    • Glycosylation and Glycoproteins Research 1
    • Cell death mechanisms and regulation 1
    • RNA Interference and Gene Delivery 1
    • Viral-associated cancers and disorders 2
    • Cancer-related Molecular Pathways 1

Jun-Min Zhou

13 papers receiving 787 citations

Jun-Min Zhou's Hit Papers

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer 2020 · 316 citations
3160+2+4Years since publication100200300

Peers

Jun-Min Zhou
Comparison fields: 5 of 70
  • Oncology 256
  • Surgery 297
  • Pathology and Forensic Medicine 73
  • Molecular Biology 282
  • Organic Chemistry 114
Replace Chang In Choi with:
Chang In Choi South Korea
Graziella Malaponte Italy
Mamoru Morimoto Japan
Shuling Huang China
Setsuo Takeda Japan
Yan‐jun Mi China
Jerzy Mielko Poland
Seiji Doi Japan
Xiqiang Cai China
Maitane Asensio Spain
Jun-Min Zhou relative to Chang In Choi South Korea Chang In Choi's profile →
Citations per field
00.5×3.3×
Chang In Choi · 1×
Citations per year

Countries citing papers authored by Jun-Min Zhou

Since Specialization
Citations

This map shows the geographic impact of Jun-Min Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-Min Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-Min Zhou more than expected).

Fields of papers citing papers by Jun-Min Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun-Min Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-Min Zhou. The network helps show where Jun-Min Zhou may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun-Min Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun-Min Zhou Line = papers co-authored together Jun-Min Zhou links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer
Hit paper breakdown →
2020316
2 2005160
3 200759
4 200559
5 200650
6 200540
7 201731
8 200822
9 200417
10 200516
11 200316
12 202010
13 20192

About Jun-Min Zhou

Jun-Min Zhou is a scholar working on Molecular Biology, Oncology, Cancer Research, Toxicology and Radiology, Nuclear Medicine and Imaging, having authored 13 papers that have together received 798 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Click Chemistry and Applications (1 paper), Glycosylation and Glycoproteins Research (1 paper), Cell death mechanisms and regulation (1 paper), Cancer, Lipids, and Metabolism (1 paper), RNA Interference and Gene Delivery (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Oncology (256 citations), Surgery (297 citations), Pathology and Forensic Medicine (73 citations), Molecular Biology (282 citations) and Organic Chemistry (114 citations). Jun-Min Zhou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiao‐Feng Zhu, Daneng Li, Taymeyah Al‐Toubah, Dae Won Kim, Michael J. Schell, Richard D. Kim, Vincent Chung, Olatunji B. Alese, Amit Mahipal and Baek‐hui Kim. Their work appears in journals such as Cancer Biology & Therapy, Journal of Radiation Research, Cancer Letters, Journal of Medicinal Chemistry and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact